U.S. stock futures are edging mostly higher as market participants focus on tech stocks and corporate earnings; Honeywell ...

US stocks were mixed on Thursday in anticipation of Amazon's quarterly results, as investors assessed the earnings season so ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

Analysts on Wall Street project that Qualcomm (QCOM) will announce quarterly earnings of $2.93 per share in its forthcoming report, representing an increase of 6.6% year over year. Revenues are ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

Shares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...

We recently published a list of Coatue’s 35 Most Important AI Stocks. In this article, we are going to take a look at where QUALCOMM Incorporated (NASDAQ:QCOM) stands against Coatue’s other most ...

Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...

Over the past six months, Eli Lilly (NYSE: LLY) has underperformed broader equities. While that's not much of an issue in the grand scheme of things, it is still a bit surprising, since the ...